Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.
about
Host response to Candida albicans bloodstream infection and sepsisHuman recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.Minimum chemical requirements for adhesin activity of the acid-stable part of Candida albicans cell wall phosphomannoprotein complex.Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans.Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast.Cell wall and secreted proteins of Candida albicans: identification, function, and expressionCanadian clinical practice guidelines for invasive candidiasis in adults.Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans.A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activityBiological activities of naturally occurring antibodies reactive with Candida albicans mannan.Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.Complement C3 plays an essential role in the control of opportunistic fungal infections.The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein.Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells.
P2860
Q27028066-4AC6793C-ECAD-4859-8880-AD98DEF1875FQ30804794-C96971A5-26AB-4F49-9E25-766CC9A264CBQ33675896-2BF346EE-B66B-4A72-8C79-FEA5EE72BAC1Q33765773-E1B8B8AE-C1AD-4C69-8760-C37B49537E05Q33768978-C6F60762-C307-434C-8210-9CFB1E41E650Q33770188-4DE723ED-4BEE-4552-9D96-3C4F981436B8Q34009739-2A1A582C-A39C-4831-A00E-30A574DEB025Q34009982-52E9CAF4-F5B2-4251-9895-1F81AD68171DQ34237335-87FA6E70-2268-4CDA-BCDF-8308F1DAB6B1Q34681238-C6F38E7B-8981-4043-B812-4EBF716366EFQ35547013-7D9BC789-B4C5-4570-A386-AC9D1CDB2750Q35555410-440108FE-66FD-4F4F-8D6E-2D0B3ADE2EDCQ35561235-5F8F7F7C-0647-4F54-9ACA-430798111A15Q36228418-1E128BA2-0460-49B1-952E-DC6B40072095Q37161587-4E983C0F-74BF-41A2-9A62-CB844CAFAABAQ37333509-D736E495-33D3-48D7-85F6-6CFD74CA02EFQ40204670-73627E7A-69CD-4F66-AC94-C9B2ADDA4990Q41842699-E1353AB8-1228-4F44-9B4A-B16965BD1921
P2860
Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Distinct characteristics of in ...... pathways by Candida albicans.
@ast
Distinct characteristics of in ...... pathways by Candida albicans.
@en
type
label
Distinct characteristics of in ...... pathways by Candida albicans.
@ast
Distinct characteristics of in ...... pathways by Candida albicans.
@en
prefLabel
Distinct characteristics of in ...... pathways by Candida albicans.
@ast
Distinct characteristics of in ...... pathways by Candida albicans.
@en
P2860
P1476
Distinct characteristics of in ...... pathways by Candida albicans.
@en
P2093
L C Weinhold
P2860
P304
P407
P577
1996-08-01T00:00:00Z